132,942 Shares in BioLife Solutions, Inc. $BLFS Bought by Squarepoint Ops LLC

Squarepoint Ops LLC acquired a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 132,942 shares of the medical equipment provider’s stock, valued at approximately $3,754,000.

Several other hedge funds have also recently added to or reduced their stakes in BLFS. Global Retirement Partners LLC acquired a new position in shares of BioLife Solutions during the 4th quarter worth about $30,000. Kemnay Advisory Services Inc. acquired a new stake in shares of BioLife Solutions in the 4th quarter valued at approximately $35,000. State of Wyoming acquired a new stake in shares of BioLife Solutions in the 1st quarter valued at approximately $52,000. Quarry LP boosted its stake in BioLife Solutions by 50.9% during the 3rd quarter. Quarry LP now owns 2,113 shares of the medical equipment provider’s stock worth $54,000 after acquiring an additional 713 shares during the last quarter. Finally, Hantz Financial Services Inc. boosted its stake in BioLife Solutions by 42.4% during the 4th quarter. Hantz Financial Services Inc. now owns 2,673 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 796 shares during the last quarter. Institutional investors and hedge funds own 93.24% of the company’s stock.

BioLife Solutions Stock Up 0.1%

Shares of NASDAQ:BLFS opened at $34.95 on Friday. BioLife Solutions, Inc. has a 12 month low of $17.86 and a 12 month high of $38.10. The company’s fifty day simple moving average is $33.07 and its 200 day simple moving average is $26.28. The firm has a market cap of $1.71 billion, a price-to-earnings ratio of 30.13 and a beta of 1.91.

BioLife Solutions (NASDAQ:BLFS) last announced its earnings results on Thursday, August 6th. The medical equipment provider reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.88. The firm had revenue of $28.47 million during the quarter, compared to analyst estimates of $27.80 million. BioLife Solutions had a net margin of 53.29% and a return on equity of 2.70%. Research analysts expect that BioLife Solutions, Inc. will post 0.03 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on BLFS. Maxim Group cut shares of BioLife Solutions from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. TD Cowen lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating and cut their target price for the stock from $33.00 to $31.00 in a report on Wednesday, July 22nd. Benchmark cut shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research report on Monday, August 10th. Stephens reissued an “equal weight” rating and issued a $31.00 price target (down from $32.00) on shares of BioLife Solutions in a report on Monday, July 27th. Finally, Wall Street Zen cut shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $31.38.

About BioLife Solutions

BioLife Solutions, Inc develops and supplies tools and services used in the development, manufacture, preservation and distribution of cell and gene therapies. Its products are designed to help maintain the viability and functionality of cells, tissues and other biological materials during processing, freezing, storage and transportation.

The company’s portfolio includes cell and tissue preservation media, thawing and processing solutions, cryogenic storage systems, controlled-rate freezing equipment and related bioproduction technologies.